The Association between Placental Abruption and Platelet Indices

Duygu Tugrul Ersak1, Özgür Kara1, Kadriye Yakut1

  • 1Ankara Dr. Zekai Tahir Burak Women's Health Training Research Hospital, Ankara, Turkey.

Insights

Platelet indices like mean platelet volume (MPV) and platelet to lymphocyte ratio (PLR) were lower, while platelet distribution width (PDW) was higher in patients with placental abruption (PA). These findings suggest potential diagnostic value for these markers in early PA assessment.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology

Background:

  • Placental abruption (PA) is a critical obstetric emergency.
  • Early diagnosis of PA is crucial for effective management and improved outcomes.

Purpose of the Study:

  • To investigate the utility of platelet indices in the early diagnosis of placental abruption (PA).
  • To assess if specific platelet parameters can aid in differentiating PA from other conditions.

Main Methods:

  • A case-control study involving 62 pregnant women with PA and 130 controls.
  • Analysis of platelet indices (MPV, PDW), biochemical, and coagulation parameters before cesarean section.
  • Recording of maternal and neonatal outcomes.

Main Results:

  • No significant differences in hemoglobin, hematocrit, or white blood cell count between groups.
  • Significantly lower platelet count, mean platelet volume (MPV), and platelet to lymphocyte ratio (PLR) in PA patients.
  • Significantly higher platelet distribution width (PDW) in PA patients compared to controls.

Conclusions:

  • Mean platelet volume (MPV) and platelet to lymphocyte ratio (PLR) were found to be lower in patients with placental abruption.
  • Platelet distribution width (PDW) was observed to be higher in placental abruption patients.
  • These platelet indices may serve as valuable biomarkers for the early assessment and diagnosis of placental abruption.

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.8K
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.3K
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
582